HRP20120937T1 - Farmaceutska smjesa koja sadrži gabapentin - Google Patents
Farmaceutska smjesa koja sadrži gabapentin Download PDFInfo
- Publication number
- HRP20120937T1 HRP20120937T1 HRP20120937TT HRP20120937T HRP20120937T1 HR P20120937 T1 HRP20120937 T1 HR P20120937T1 HR P20120937T T HRP20120937T T HR P20120937TT HR P20120937 T HRP20120937 T HR P20120937T HR P20120937 T1 HRP20120937 T1 HR P20120937T1
- Authority
- HR
- Croatia
- Prior art keywords
- mixture
- mixture according
- present
- filler
- calcium
- Prior art date
Links
- UGJMXCAKCUNAIE-UHFFFAOYSA-N Gabapentin Chemical compound OC(=O)CC1(CN)CCCCC1 UGJMXCAKCUNAIE-UHFFFAOYSA-N 0.000 title claims 8
- 229960002870 gabapentin Drugs 0.000 title claims 4
- 239000008194 pharmaceutical composition Substances 0.000 title claims 2
- 239000000203 mixture Substances 0.000 claims 21
- 239000000945 filler Substances 0.000 claims 8
- 235000010443 alginic acid Nutrition 0.000 claims 4
- 239000000783 alginic acid Substances 0.000 claims 4
- 229920000615 alginic acid Polymers 0.000 claims 4
- 229960001126 alginic acid Drugs 0.000 claims 4
- 150000004781 alginic acids Chemical class 0.000 claims 4
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 claims 3
- 239000002253 acid Substances 0.000 claims 3
- 159000000007 calcium salts Chemical class 0.000 claims 3
- 235000010418 carrageenan Nutrition 0.000 claims 3
- 239000000679 carrageenan Substances 0.000 claims 3
- 229920001525 carrageenan Polymers 0.000 claims 3
- 229940113118 carrageenan Drugs 0.000 claims 3
- 239000000314 lubricant Substances 0.000 claims 3
- 239000000600 sorbitol Substances 0.000 claims 3
- 235000010356 sorbitol Nutrition 0.000 claims 3
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 claims 3
- OMDQUFIYNPYJFM-XKDAHURESA-N (2r,3r,4s,5r,6s)-2-(hydroxymethyl)-6-[[(2r,3s,4r,5s,6r)-4,5,6-trihydroxy-3-[(2s,3s,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]methoxy]oxane-3,4,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O[C@H]2[C@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)[C@H](O)[C@H](O)[C@H](O)O1 OMDQUFIYNPYJFM-XKDAHURESA-N 0.000 claims 2
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 claims 2
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 claims 2
- 229920000926 Galactomannan Polymers 0.000 claims 2
- 229930195725 Mannitol Natural products 0.000 claims 2
- 239000002775 capsule Substances 0.000 claims 2
- 239000004359 castor oil Substances 0.000 claims 2
- 235000019438 castor oil Nutrition 0.000 claims 2
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 claims 2
- 239000000594 mannitol Substances 0.000 claims 2
- 235000010355 mannitol Nutrition 0.000 claims 2
- 239000001814 pectin Substances 0.000 claims 2
- 235000010987 pectin Nutrition 0.000 claims 2
- 229920001277 pectin Polymers 0.000 claims 2
- 229960000292 pectin Drugs 0.000 claims 2
- 150000003839 salts Chemical class 0.000 claims 2
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 claims 2
- 235000019731 tricalcium phosphate Nutrition 0.000 claims 2
- SERLAGPUMNYUCK-DCUALPFSSA-N 1-O-alpha-D-glucopyranosyl-D-mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O SERLAGPUMNYUCK-DCUALPFSSA-N 0.000 claims 1
- OKMWKBLSFKFYGZ-UHFFFAOYSA-N 1-behenoylglycerol Chemical compound CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(O)CO OKMWKBLSFKFYGZ-UHFFFAOYSA-N 0.000 claims 1
- PYMYPHUHKUWMLA-UHFFFAOYSA-N 2,3,4,5-tetrahydroxypentanal Chemical compound OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 claims 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 claims 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims 1
- 239000004386 Erythritol Substances 0.000 claims 1
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 claims 1
- 239000005715 Fructose Substances 0.000 claims 1
- 229930091371 Fructose Natural products 0.000 claims 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 claims 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims 1
- 229920002907 Guar gum Polymers 0.000 claims 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims 1
- 239000005913 Maltodextrin Substances 0.000 claims 1
- 229920002774 Maltodextrin Polymers 0.000 claims 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 claims 1
- 229930006000 Sucrose Natural products 0.000 claims 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 claims 1
- 150000007513 acids Chemical class 0.000 claims 1
- 239000013543 active substance Substances 0.000 claims 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 claims 1
- 239000011575 calcium Substances 0.000 claims 1
- 229910052791 calcium Inorganic materials 0.000 claims 1
- 235000010410 calcium alginate Nutrition 0.000 claims 1
- 239000000648 calcium alginate Substances 0.000 claims 1
- 229960002681 calcium alginate Drugs 0.000 claims 1
- OKHHGHGGPDJQHR-YMOPUZKJSA-L calcium;(2s,3s,4s,5s,6r)-6-[(2r,3s,4r,5s,6r)-2-carboxy-6-[(2r,3s,4r,5s,6r)-2-carboxylato-4,5,6-trihydroxyoxan-3-yl]oxy-4,5-dihydroxyoxan-3-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylate Chemical compound [Ca+2].O[C@@H]1[C@H](O)[C@H](O)O[C@@H](C([O-])=O)[C@H]1O[C@H]1[C@@H](O)[C@@H](O)[C@H](O[C@H]2[C@H]([C@@H](O)[C@H](O)[C@H](O2)C([O-])=O)O)[C@H](C(O)=O)O1 OKHHGHGGPDJQHR-YMOPUZKJSA-L 0.000 claims 1
- 238000006243 chemical reaction Methods 0.000 claims 1
- 239000003795 chemical substances by application Substances 0.000 claims 1
- 229940040387 citrus pectin Drugs 0.000 claims 1
- 239000009194 citrus pectin Substances 0.000 claims 1
- 239000008121 dextrose Substances 0.000 claims 1
- 235000019414 erythritol Nutrition 0.000 claims 1
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 claims 1
- 229940009714 erythritol Drugs 0.000 claims 1
- 229940049654 glyceryl behenate Drugs 0.000 claims 1
- 235000010417 guar gum Nutrition 0.000 claims 1
- 239000000665 guar gum Substances 0.000 claims 1
- 229960002154 guar gum Drugs 0.000 claims 1
- 239000012535 impurity Substances 0.000 claims 1
- 239000000905 isomalt Substances 0.000 claims 1
- 235000010439 isomalt Nutrition 0.000 claims 1
- HPIGCVXMBGOWTF-UHFFFAOYSA-N isomaltol Natural products CC(=O)C=1OC=CC=1O HPIGCVXMBGOWTF-UHFFFAOYSA-N 0.000 claims 1
- 150000003951 lactams Chemical class 0.000 claims 1
- 235000010449 maltitol Nutrition 0.000 claims 1
- 239000000845 maltitol Substances 0.000 claims 1
- VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 claims 1
- 229940035436 maltitol Drugs 0.000 claims 1
- 229940035034 maltodextrin Drugs 0.000 claims 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 claims 1
- -1 monosaccharide sugars Chemical class 0.000 claims 1
- 239000000546 pharmaceutical excipient Substances 0.000 claims 1
- 229920001282 polysaccharide Polymers 0.000 claims 1
- 239000005017 polysaccharide Substances 0.000 claims 1
- 150000004804 polysaccharides Chemical class 0.000 claims 1
- 229910052700 potassium Inorganic materials 0.000 claims 1
- 235000010408 potassium alginate Nutrition 0.000 claims 1
- 239000000737 potassium alginate Substances 0.000 claims 1
- XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical compound [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 claims 1
- 230000001737 promoting effect Effects 0.000 claims 1
- 229910052708 sodium Inorganic materials 0.000 claims 1
- 235000010413 sodium alginate Nutrition 0.000 claims 1
- 239000000661 sodium alginate Substances 0.000 claims 1
- 235000002639 sodium chloride Nutrition 0.000 claims 1
- 239000005720 sucrose Substances 0.000 claims 1
- 235000000346 sugar Nutrition 0.000 claims 1
- 239000000811 xylitol Substances 0.000 claims 1
- 235000010447 xylitol Nutrition 0.000 claims 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 claims 1
- 229960002675 xylitol Drugs 0.000 claims 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/485—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4866—Organic macromolecular compounds
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Engineering & Computer Science (AREA)
- Pain & Pain Management (AREA)
- Inorganic Chemistry (AREA)
- Rheumatology (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Claims (15)
1. Stabilna farmaceutska smjesa koja sadrži gabapentin kao djelatnu tvar, naznačena time što također sadrži mješavinu pomoćnih tvari koje su sposobne ne promovirati pretvorbu gabapentina u odgovarajuće laktamsko onečišćenje, a mješavina sadrži: (i) sredstvo za kliženje (glidant) izabrano između kalcijeve soli slabe kiseline, (ii) sredstvo za podmazivanje (lubrikant) izabrano između hidrogeniranog ricinusovog ulja i gliceril behenata; i po izboru (iii) punilo, samo ili pomiješano s jednim ili više drugih punila, izabrano između monosaharidnog šećera kao što su sorbitol, ksilitol, manitol, fruktoza, dekstroza i eritritol i polisaharidnih derivata kao što su saharoza, manitol, izomalt, maltitol, galaktomanan, alginska kiselina ili jedna od njezinih soli, pektin, karagenan i maltodekstrin.
2. Smjesa prema zahtjevu 1, gdje je gabapentin prisutan u količini koja može varirati između 50% i 99% ukupne težine smjese.
3. Smjesa prema zahtjevu 1, gdje je glidant prisutan u količini koja može varirati između 0.5% i 5% ukupne težine smjese.
4. Smjesa prema zahtjevu 1, gdje je lubrikant prisutan u količini koja može varirati između 0.1% i 8% ukupne težine smjese.
5. Smjesa prema zahtjevu 1, gdje je punilo prisutno u količini koja može varirati između 0% i 50% ukupne težine smjese.
6. Smjesa prema zahtjevu 1, gdje je kalcijeva sol slabe kiseline tribazični kalcijev fosfat.
7. Smjesa prema zahtjevu 1, gdje je punilo prisutno u mješavini s jednim ili više punila izabranih između onih opisanih u zahtjevu 1.
8. Smjesa prema zahtjevu 7, gdje su punila u smjesi sorbitol i alginska kiselina.
9. Smjesa prema zahtjevu 1, gdje galaktomanan je guar guma.
10. Smjesa prema zahtjevu 1, gdje je sol alginske kiseline natrijev, kalijev ili kalcijev alginat.
11. Smjesa prema zahtjevu 1, gdje je pektin citrusni pektin.
12. Smjesa prema zahtjevu 1, gdje karagenan je kapa, jot, lambda ili ksi karagenan, ili njegova kalcijeva, amonijeva ili kalijeva sol.
13. Farmaceutska smjesa prema zahtjevu 1, gdje je kalcijeva sol slabe kiseline tribazični kalcijev fosfat, lubrikant je hidrogenirano ricinusovo ulje, i sorbitol kao punilo je prisutan u mješavini s drugim punilo koje je alginska kiselina.
14. Uporaba farmaceutske smjese prema zahtjevu 1, za pripremu kapsula.
15. Kapsule koje sadrže farmaceutsku smjesu prema zahtjevu 1.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT001447A ITMI20041447A1 (it) | 2004-07-20 | 2004-07-20 | Composizione farmaceutica comprendente gabapentina |
PCT/EP2005/053473 WO2006008295A1 (en) | 2004-07-20 | 2005-07-19 | A pharmaceutical composition comprising gabapentin |
Publications (1)
Publication Number | Publication Date |
---|---|
HRP20120937T1 true HRP20120937T1 (hr) | 2012-12-31 |
Family
ID=35106902
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HRP20120937TT HRP20120937T1 (hr) | 2004-07-20 | 2012-11-19 | Farmaceutska smjesa koja sadrži gabapentin |
Country Status (19)
Country | Link |
---|---|
US (1) | US20080058420A1 (hr) |
EP (1) | EP1784174B1 (hr) |
JP (1) | JP5022896B2 (hr) |
CN (1) | CN101001621A (hr) |
AU (1) | AU2005263754B2 (hr) |
BR (1) | BRPI0513566B8 (hr) |
CA (1) | CA2573985C (hr) |
DK (1) | DK1784174T3 (hr) |
EA (1) | EA012081B1 (hr) |
ES (1) | ES2394506T3 (hr) |
HR (1) | HRP20120937T1 (hr) |
IL (1) | IL180631A (hr) |
IT (1) | ITMI20041447A1 (hr) |
NZ (1) | NZ552673A (hr) |
PL (1) | PL1784174T3 (hr) |
PT (1) | PT1784174E (hr) |
SI (1) | SI1784174T1 (hr) |
WO (1) | WO2006008295A1 (hr) |
ZA (1) | ZA200700511B (hr) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
HU230031B1 (hu) * | 2010-03-01 | 2015-05-28 | Egis Gyógyszergyár Nyilvánosan Működő Részvénytársaság | Pregabalint és izomaltot tartalmazó stabilizált gyógyszerkészítmény |
US9271951B2 (en) | 2012-12-21 | 2016-03-01 | Mylan Inc. | Levothyroxine formulation with acacia |
US20140179784A1 (en) * | 2012-12-21 | 2014-06-26 | Mylan Inc. | Levothyroxine formulation with carrageenan |
WO2015175982A1 (en) * | 2014-05-16 | 2015-11-19 | Vivus, Inc. | Orally administrable formulations for the controlled release of a pharmacologically active agent |
WO2016075704A2 (en) * | 2014-11-15 | 2016-05-19 | Eris Lifesciences Pvt Ltd. | Stable topical pharmaceutical compositions comprising gabapentin |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3928183A1 (de) * | 1989-08-25 | 1991-02-28 | Goedecke Ag | Lactamfreie cyclische aminosaeuren |
DE60022333T2 (de) * | 1999-04-09 | 2006-07-06 | Euro-Celtique S.A. | Natrium kanalblocker zusammensetzungen und deren verwendung |
US6294198B1 (en) * | 1999-08-24 | 2001-09-25 | Purepac Pharmaceutical Co. | Pharmaceutical tablet formulation containing gabapentin with improved physical and chemical characteristics and method of making the same |
US7056951B2 (en) * | 2000-09-26 | 2006-06-06 | Mutual Pharmaceutical Co., Inc. | Stable solid dosage forms of amino acids and processes for producing same |
JP4438268B2 (ja) * | 2001-03-07 | 2010-03-24 | 大日本住友製薬株式会社 | 薬物顆粒の製造方法、および薬物顆粒、ならびにそれを用いた医薬製剤 |
US20040010035A1 (en) * | 2002-07-15 | 2004-01-15 | Ciociola Arthur A. | Gastrointestinal compositions |
JP2005533100A (ja) * | 2002-07-10 | 2005-11-04 | ワーナー−ランバート・カンパニー、リミテッド、ライアビリティ、カンパニー | Gaba誘導体を含む胃腸用組成物 |
CA2395931A1 (en) * | 2002-08-07 | 2004-02-07 | Bernard Charles Sherman | Solid compositions comprising gabapentin having improved stability |
GB0219024D0 (en) * | 2002-08-15 | 2002-09-25 | Pfizer Ltd | Synergistic combinations |
US20040092522A1 (en) * | 2002-08-15 | 2004-05-13 | Field Mark John | Synergistic combinations |
WO2005046566A2 (en) * | 2003-08-04 | 2005-05-26 | Sun Pharmaceutical Industries Limited | Stable gabapentin containing composition |
-
2004
- 2004-07-20 IT IT001447A patent/ITMI20041447A1/it unknown
-
2005
- 2005-07-19 BR BRPI0513566A patent/BRPI0513566B8/pt active IP Right Grant
- 2005-07-19 CA CA2573985A patent/CA2573985C/en active Active
- 2005-07-19 CN CNA2005800271182A patent/CN101001621A/zh active Pending
- 2005-07-19 EP EP05774174A patent/EP1784174B1/en active Active
- 2005-07-19 ES ES05774174T patent/ES2394506T3/es active Active
- 2005-07-19 NZ NZ552673A patent/NZ552673A/en unknown
- 2005-07-19 WO PCT/EP2005/053473 patent/WO2006008295A1/en active Application Filing
- 2005-07-19 PL PL05774174T patent/PL1784174T3/pl unknown
- 2005-07-19 SI SI200531627T patent/SI1784174T1/sl unknown
- 2005-07-19 AU AU2005263754A patent/AU2005263754B2/en active Active
- 2005-07-19 EA EA200700203A patent/EA012081B1/ru unknown
- 2005-07-19 PT PT57741746T patent/PT1784174E/pt unknown
- 2005-07-19 JP JP2007521947A patent/JP5022896B2/ja active Active
- 2005-07-19 US US11/572,247 patent/US20080058420A1/en not_active Abandoned
- 2005-07-19 DK DK05774174.6T patent/DK1784174T3/da active
-
2007
- 2007-01-10 IL IL180631A patent/IL180631A/en active IP Right Grant
- 2007-01-17 ZA ZA200700511A patent/ZA200700511B/xx unknown
-
2012
- 2012-11-19 HR HRP20120937TT patent/HRP20120937T1/hr unknown
Also Published As
Publication number | Publication date |
---|---|
DK1784174T3 (da) | 2012-12-10 |
AU2005263754A1 (en) | 2006-01-26 |
BRPI0513566B8 (pt) | 2021-05-25 |
SI1784174T1 (sl) | 2013-01-31 |
ES2394506T3 (es) | 2013-02-01 |
US20080058420A1 (en) | 2008-03-06 |
EA012081B1 (ru) | 2009-08-28 |
AU2005263754B2 (en) | 2010-09-23 |
PL1784174T3 (pl) | 2013-01-31 |
NZ552673A (en) | 2011-03-31 |
EA200700203A1 (ru) | 2007-06-29 |
CA2573985C (en) | 2013-02-05 |
BRPI0513566B1 (pt) | 2019-09-10 |
ITMI20041447A1 (it) | 2004-10-20 |
WO2006008295A1 (en) | 2006-01-26 |
EP1784174A1 (en) | 2007-05-16 |
PT1784174E (pt) | 2012-12-17 |
ZA200700511B (en) | 2008-09-25 |
IL180631A (en) | 2012-08-30 |
EP1784174B1 (en) | 2012-09-05 |
IL180631A0 (en) | 2008-04-13 |
JP2008506751A (ja) | 2008-03-06 |
CA2573985A1 (en) | 2006-01-26 |
CN101001621A (zh) | 2007-07-18 |
BRPI0513566A (pt) | 2008-05-06 |
JP5022896B2 (ja) | 2012-09-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2925286T3 (es) | Producto de fibra vegetal y procedimiento para su fabricación | |
HRP20120937T1 (hr) | Farmaceutska smjesa koja sadrži gabapentin | |
JP5841151B2 (ja) | 鼻腔噴霧剤 | |
FI3370692T3 (fi) | Nenän tukkoisuutta poistava koostumus, jolla on antiviraalinen aktiivisuus | |
JP2018523635A5 (hr) | ||
HRP20171518T1 (hr) | Tabletni pripravak bez prouzrokovanja kvarova kod tabletiranja | |
HRP20130109T4 (hr) | Formulacije kaspofungina | |
JP2004123760A5 (hr) | ||
RU98122230A (ru) | Трансбуккальная система доставки | |
HRP20210555T1 (hr) | Orodisperzibilna tableta koja sadrži estetrol | |
SI2023958T1 (en) | A pharmaceutical product for intravenous administration of nicotine, comprising trometamol as a buffer agent | |
RU2012140015A (ru) | Новые композиции подсластителей | |
RU2010141595A (ru) | Композиция жевательной резинки (варианты) и ее наполнитель | |
HRP20161080T1 (hr) | Farmaceutski pripravak za liječenje prehlade ili grlobolje | |
TW200833376A (en) | Sustained-release composition and method for producing the same | |
HRP20201696T1 (hr) | Farmaceutska parenteralna formulacija koja sadrži kargluminsku kiselinu | |
PE20080149A1 (es) | Formulacion liquida acuosa que comprende un beta bloqueador | |
RU2019110218A (ru) | Новые композиции на основе фуразидина и способы их изготовления | |
JP6001108B2 (ja) | 植物繊維製品およびその製造方法 | |
EA200701525A1 (ru) | Фармацевтическая полимерная композиция для перорального введения тербуталина сульфата с контролируемым высвобождением | |
HRP20211796T1 (hr) | Sastavi ibuprofena za izravnu oralnu primjenu | |
ES2796055T3 (es) | Co-granulados de goma xantana y de goma acacia | |
JP5650427B2 (ja) | 医薬用ゼリー組成物 | |
JP2019094272A (ja) | 漢方ゼリー医薬組成物 | |
TH1703000783C3 (th) | สูตรผลิตภัณฑ์เจลน้ำมะพร้าวอ่อนผง |